Review Article
Valuing the Economic Costs of Allergic Rhinitis, Acute Bronchitis, and Asthma from Exposure to Indoor Dampness and Mold in the US
Table 1
Meta-analysis results for risk and attributable fractions of risks of selected diseases from indoor dampness and mold exposure.
| Reference | Disease | Disease prevalence | Risk factor | OR (95% CI) | AF |
| Jaakkola et al. [8] | Allergic rhinitis | 0.075 | Visible mold | 1.51 (1.39–1.64) | 0.15 |
| Fisk et al. [9] | Current asthma | 0.082 | Dampness &/or mold | 1.56 (1.30–1.86) | 0.16 |
| Fisk et al. [10] | Acute bronchitis | 0.050 | Dampness &/or mold | 1.45 (1.31–1.59) | 0.14 |
|
|
CDC [14] and Worrall [15].
|